Vancouver, Canada

Mikhail A Chafeev

USPTO Granted Patents = 29 


 

Average Co-Inventor Count = 6.1

ph-index = 11

Forward Citations = 329(Granted Patents)


Location History:

  • Vancouver, CA (2002 - 2013)
  • Himki, RU (2013)
  • Abbott Park, IL (US) (2016)
  • Burnaby, CA (2010 - 2017)
  • Toronto, CA (2018)
  • Khimki, RU (2014 - 2021)
  • Kiev, UA (2022)

Company Filing History:


Years Active: 2002-2022

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):

Title: **Mikhail A. Chafeev: Innovator in Pharmaceutical Patents**

Introduction

Mikhail A. Chafeev, based in Vancouver, CA, is a prominent inventor in the pharmaceutical field, holding a remarkable portfolio of 29 patents. His innovative contributions focus primarily on the development of compounds that have significant therapeutic potential, particularly in the area of metabolic disorders.

Latest Patents

Chafeev's latest patents include groundbreaking compounds that contain polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide. These compounds have been identified as agonists of G protein-coupled receptor 119 (GPR119), which play a vital role in the treatment of diseases and conditions associated with GPR119 dysregulation, such as Type 2 diabetes mellitus and related metabolic disorders. The intricate structure of these compounds allows for various combinations of functional groups, making them versatile for future therapeutic applications.

Career Highlights

Throughout his career, Mikhail Chafeev has made significant strides in the pharmaceutical industry, having worked with renowned companies such as Xenon Pharmaceuticals Inc. and AbbVie Inc. His expertise and innovative mindset have led to the development of novel pharmaceutical solutions that have the potential to improve patient outcomes significantly.

Collaborations

Chafeev's collaborative efforts have also been instrumental in his success as an inventor. He has worked alongside talented colleagues such as Sultan Chowdhury and Jianmin Fu, fostering an environment where innovation can thrive. Together, they contributed to advancements in the field of biochemistry and pharmacology.

Conclusion

Mikhail A. Chafeev exemplifies the role of a dedicated inventor in the pharmaceutical industry, with a strong track record of patents that address critical health challenges. His contributions not only reflect his expertise but also highlight the importance of continuous innovation in improving healthcare solutions for diseases like Type 2 diabetes. As he continues to forge a path in research and development, the impact of his work will undoubtedly resonate in the field for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…